Similarly, Li et al. developed a radiomics model predicting prognosis in stage IV ALK-positive NSCLC, with a concordance index of 0.717 and an AUC of 0.824 in their validation cohort [51]. Here, ALK is linked to non-small cell lung carcinoma.